Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Double-Blind, Randomized Controlled Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects With Psoriatic Arthritis

NCT02376790 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT02376790
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02376790 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Double-Blind, Randomized Controlled Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects With Psoriatic Arthritis
Lead sponsor
Amgen
Phase
Phase 3
Overall status
Completed
Start date
March 3, 2015
Completion date
July 6, 2018
Enrollment
851 (actual)
Sites
138

Conditions

As the registry lists them; a condition with its own page is linked.

psoriatic arthritis